US Map / Nevada
State NV

Clinical Trials in Nevada

Recruiting clinical trials with at least one study location in Nevada. Data updated daily from ClinicalTrials.gov.

Total Trials
86
Recruiting Now
86
← Back to US Map
Top Conditions in Nevada
Breast Cancer (5)Chronic Lymphocytic Leukemia (3)Hypertension (3)Asthma (2)Uncontrolled Hypertension (2)Small Lymphocytic Lymphoma (2)Schizophrenia (2)Geographic Atrophy (2)Acupuncture (2)Parkinson Disease (2)Non-small Cell Lung Cancer (1)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 86 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 86. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Chronic Lymphocytic Leukemia, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT03877653 N/A
Recruiting
Freedom-1 Study for Chronic Knee Pain
Condition
Osteoarthritic Knee Pain
Enrollment
100 pts
Location
United States
Sponsor
Curonix LLC
View Trial →
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
200 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
View Trial →
NCT06632457 Phase 3
Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a L...
Condition
Metabolic Dysfunction Associated Steatohepatitis
Enrollment
1,590 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06576271 Phase 1
Recruiting
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE...
Condition
Systemic Lupus Erythematosus
Enrollment
142 pts
Location
United States, Argentina, Brazil
Sponsor
GlaxoSmithKline
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT06951711 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic ...
Condition
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Enrollment
274 pts
Location
United States, Croatia, India
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06588478 Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With...
Condition
Chronic Lymphocytic Leukemia
Enrollment
249 pts
Location
United States, Australia, Belgium
Sponsor
Loxo Oncology, Inc.
View Trial →
NCT06760637 Phase 3
Recruiting
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Bre...
Condition
Breast Cancer
Enrollment
1,020 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
View Trial →
NCT06948422 Phase 3
Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension...
Condition
Hypertension
Enrollment
974 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07090161 Phase 2
Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participan...
Condition
Hypertension
Enrollment
240 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT05516862 N/A
Recruiting
Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma
Condition
PTSD
Enrollment
75 pts
Location
United States
Sponsor
Paul Crawford
View Trial →
NCT05558527 N/A
Recruiting
The Social Regulation of Threat-related Vigilance and Arousal
Condition
Psychological Trauma, Historical
Enrollment
45 pts
Location
United States
Sponsor
University of Nevada, Reno
View Trial →
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
View Trial →
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
View Trial →
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
750 pts
Location
United States, France, Germany
Sponsor
Greenwich LifeSciences, Inc.
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07154823 N/A
Recruiting
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients ...
Condition
Acute Myeloid Leukaemia (AML)
Enrollment
550 pts
Location
United States
Sponsor
Tempus AI
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06388590 N/A
Recruiting
Acupuncture for Chronic Pelvic Pain
Condition
Pelvic Pain
Enrollment
64 pts
Location
United States
Sponsor
David Moss
View Trial →
NCT06504446 Phase 2
Recruiting
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With...
Condition
Refractory or Unexplained Chronic Cough
Enrollment
455 pts
Location
United States, Belgium, Canada
Sponsor
Nocion Therapeutics
View Trial →
NCT06989437 Phase 2, Phase 3
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pan...
Condition
Cachexia
Enrollment
982 pts
Location
United States, Australia, Brazil
Sponsor
Pfizer
View Trial →
NCT05156398 Phase 3
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai...
Condition
Migraine
Enrollment
640 pts
Location
United States, Canada, France
Sponsor
Pfizer
View Trial →
Page 2 of 4 — 86 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology